| Literature DB >> 25781022 |
Arata Hidano1, Takehisa Yamamoto2, Yoko Hayama2, Norihiko Muroga2, Sota Kobayashi2, Takeshi Nishida3, Toshiyuki Tsutsui2.
Abstract
Multidrug-resistant enterococci are considered crucial drivers for the dissemination of antimicrobial resistance determinants within and beyond a genus. These organisms may pass numerous resistance determinants to other harmful pathogens, whose multiple resistances would cause adverse consequences. Therefore, an understanding of the coexistence epidemiology of resistance genes is critical, but such information remains limited. In this study, our first objective was to determine the prevalence of principal resistance phenotypes and genes among Enterococcus faecalis isolated from retail chicken domestic products collected throughout Japan. Subsequent analysis of these data by using an additive Bayesian network (ABN) model revealed the co-appearance patterns of resistance genes and identified the associations between resistance genes and phenotypes. The common phenotypes observed among E. faecalis isolated from the domestic products were the resistances to oxytetracycline (58.4%), dihydrostreptomycin (50.4%), and erythromycin (37.2%), and the gene tet(L) was detected in 46.0% of the isolates. The ABN model identified statistically significant associations between tet(L) and erm(B), tet(L) and ant(6)-Ia, ant(6)-Ia and aph(3')-IIIa, and aph(3')-IIIa and erm(B), which indicated that a multiple-resistance profile of tetracycline, erythromycin, streptomycin, and kanamycin is systematic rather than random. Conversely, the presence of tet(O) was only negatively associated with that of erm(B) and tet(M), which suggested that in the presence of tet(O), the aforementioned multiple resistance is unlikely to be observed. Such heterogeneity in linkages among genes that confer the same phenotypic resistance highlights the importance of incorporating genetic information when investigating the risk factors for the spread of resistance. The epidemiological factors that underlie the persistence of systematic multiple-resistance patterns warrant further investigations with appropriate adjustments for ecological and bacteriological factors.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25781022 PMCID: PMC4363150 DOI: 10.1371/journal.pone.0121189
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Map of Japan showing the study area.
A choropleth map of 46 Japanese administrative areas (prefectures) showing the origin of the purchased domestic chicken products and the quantity of products supplied from each prefecture. The origin of 82 domestic products (52.6%) was unavailable and is not shown. The superimposed points show the locations of the 5 Japanese cities where chicken products were purchased between July and August 2012.
Prevalence of phenotypic resistance for the tested antimicrobials among isolated Enterococci.
| Antimicrobial agent |
|
|
|---|---|---|
| Ampicillin (8 μg/mL) | 0 (0) | 1 (4) |
| Dihydrostreptomycin (128 μg/mL) | 57 (50.4) | 5 (20) |
| Oxytetracycline (16 μg/mL) | 66 (58.4) | 7 (28) |
| Chloramphenicol (64 μg/mL) | 7 (6.2) | 0 (0) |
| Erythromycin (8 μg/mL) | 42 (37.2) | 11 (44) |
| Enrofloxacin (4 μg/mL) | 3 (2.7) | 8 (32) |
| Vancomycin (8 μg/mL) | 1 (0.9) | 1 (4) |
| Virginamycin (64 or 8 μg/mL) | 0 (0) | 3 (12) |
Prevalence of resistance to each tested antimicrobial in E. faecalis and E. faecium isolated from retail poultry products collected in 5 major Japanese cities between July and August 2012.
aBreakpoints for E. faecalis and E. faecium were 64 and 8 μg/mL, respectively.
Prevalence of tested resistance genes among isolated Enterococci.
| Antimicrobial resistance gene |
|
|
|---|---|---|
|
| 5 (4.4) | 0 (0) |
|
| 28 (24.8) | 1 (4) |
|
| 23 (20.4) | 1 (4) |
|
| 52 (46.0) | 6 (24) |
|
| 38 (33.6) | 5 (20) |
|
| 15 (13.3) | 0 (0) |
|
| 0 (0) | 0 (0) |
|
| 32 (28.3) | 2 (8) |
|
| 0 (0) | 0 (0) |
|
| 0 (0) | 0 (0) |
Prevalence of antimicrobial resistance genes tested among E. faecalis and E. faecium isolated from retail poultry products collected in 5 major Japanese cities between July and August 2012.
Fig 2Initial optimal additive Bayesian network model.
Identified interrelationships between selected antimicrobial resistance genes and their effects on the phenotypic expressions of resistance among 113 isolates of Enterococcus faecalis from domestic poultry products collected from retail shops in 5 major Japanese cities between July and August 2012. Abbreviations: ant6: ant(6)-Ia; aph3: aph(3’)-IIIa; EM: erythromycin resistance; DSM_L: MIC for dihydrostreptomycin ≥128 μg/mL and ≤512 μg/mL; DSM_H: MIC for dihydrostreptomycin >512 μg/mL; OTC_L: MIC for oxytetracycline ≥16 μg/mL and ≤64 μg/mL; OTC_H: MIC for oxytetracycline >64 μg/mL. Solid lines and dashed lines represent positive and negative associations between variables, respectively.
Fig 3Final globally optimal additive Bayesian network model after adjustment for over-fitting.
Final additive Bayesian network model after removing arcs that appeared in <50% of bootstrappings for the interrelationships between selected antimicrobial resistance genes and phenotypes. Solid lines and dashed lines represent positive and negative associations between variables, respectively. Fig. 2 lists the variable names.
Posterior marginal log odds ratios for parameters.
| Arc | Log odds | |||
|---|---|---|---|---|
| Child | Parent | Median | Credibility interval | |
| 50% | 2.50% | 97.50% | ||
|
|
| 17.31 | 6.43 | 43.35 |
|
|
| 15.00 | 4.39 | 40.95 |
|
|
| −2.90 | −6.23 | −0.98 |
|
|
| 2.30 | 1.34 | 3.38 |
|
|
| −3.21 | −6.56 | −1.29 |
|
|
| 2.17 | 1.27 | 3.15 |
|
|
| 2.18 | 1.08 | 3.52 |
| Dihydrostreptomycin (Low) |
| −2.58 | −5.90 | −0.78 |
| Dihydrostreptomycin (High) |
| 7.53 | 4.82 | 12.13 |
| Dihydrostreptomycin (High) |
| 3.33 | 1.36 | 6.63 |
| Erythromycin |
| 24.88 | 5.45 | 70.54 |
| Oxytetracycline (Low) |
| 3.27 | 1.73 | 5.12 |
| Oxytetracycline (Low) |
| 6.03 | 3.81 | 8.78 |
| Oxytetracycline (Low) |
| −3.93 | −6.28 | −2.16 |
| Oxytetracycline (High) |
| −4.25 | −6.66 | −2.37 |
| Oxytetracycline (High) |
| 7.10 | 4.97 | 10.51 |
Posterior estimates for remaining arcs obtained from the final ABN model after bootstrapping. The median and 95% credibility intervals for each parameter estimate are shown.
aMIC for dihydrostreptomycin: ≥128 μg/mL and ≤512 μg/mL.
bMIC for dihydrostreptomycin: >512 μg/mL.
cMIC for oxytetracycline: ≥16 μg/mL and ≤64 μg/mL.
dMIC for oxytetracycline: >64 μg/mL.